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Abstract 
Antimicrobial resistance among Gram-negative bacteria is a growing problem, fueled 
by the paucity of new antibiotics that target these microorganisms. One novel family 
of macrocyclic ß-hairpin-shaped peptidomimetics was recently shown to act 
specifically against Pseudomonas spp. by a novel mechanism of action, targeting the 
outer membrane protein LptD, which mediates lipopolysaccharide transport to the cell 
surface during outer membrane biogenesis. Here we explore the mode of binding of 
one of these ß-hairpin peptidomimetics to LptD in P. aeruginosa, by examining the 
effects on antimicrobial activity following N-methylation of individual peptide bonds. 
An N-methyl scan of the cyclic peptide revealed that residues on both sides of the ß-
hairpin structure at a non-hydrogen bonding position likely mediate hydrogen-
bonding interactions with the target LptD. Structural analyses by NMR spectroscopy 
further reinforce the conclusion that the folded ß-hairpin structure of the 
peptidomimetic is critical for binding to the target LptD. Finally, new NMe analogues 
with potent activity have been identified, which opens new avenues for optimization 
in this family of antimicrobial peptides. 
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1. Introduction 
The macrocyclic ß-hairpin-shaped peptides shown in Figure 1A represent a new class 
of antibiotics with potent antimicrobial activity against Gram-negative Pseudomonas 
spp. including the important human pathogen P. aeruginosa (PA).1,2 Their unique 
mechanism of action involves binding to the outer membrane (OM) protein LptD in 
PA and inhibition of its essential role in lipopolysaccharide (LPS) transport to the cell 
surface.3 Seven essential LPS transport (Lpt) proteins (LptA-G) in Gram-negative 
bacteria mediate LPS transport from the inner to the OM. After extraction from the 
inner membrane, LPS travels along a bridge formed by LptA oligomers extending 
across the periplasm, and is delivered to LptD in the OM, driven by ATP hydrolysis 
in the cytoplasm (Figure 1B).4 The function of LptD has been studied most 
thoroughly in Escherichia coli, where in a complex with the lipoprotein LptE it 
fulfills the final step in the biogenesis of the OM, by translocating LPS molecules 
delivered by LptA from the periplasmic face into the outer leaflet of the asymmetric 
OM.5,6 During exponential growth it has been estimated that in each cell typically 
≈1200 LPS molecules per second are exported by LptD to the cell surface during OM 
biogenesis.7 
 Recently the crystal structure of the full length LptD/E complex from Shigella 
flexneri was reported, which revealed a C-terminal 26-stranded ß-barrel integral 
membrane domain, conserved in other Gram-negative bacteria, with the lipoprotein 
LptE enclosed within the ß-barrel (Figure 1C).8 The ß-barrel domain is inserted in and 
traverses the OM, while a conserved N-terminal ß-jelly-roll domain in LptD sits 
underneath in the periplasm and is disulfide-bonded to the ß-barrel. The jelly-roll is 
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the site to which LPS molecules are delivered to LptD by LptA. The lipoprotein LptE 
binds inside and acts like a plug in the LptD ß-barrel. 
Figure 1. A, Peptidomimetics L27-11 and LB-01 (Dab = L-2,4-diaminobutyric acid; 
Orn = L-ornithine). B, Schematic view of LPS transport to the OM mediated by the 
Lpt protein family (see text) (OM = outer membrane; IM = inner membrane; PG = 
peptidoglycan; PG/PE, phosphatidylglycerol/ethanolamine). C, Ribbon representation 
of the Shigella flexneri LptD/E crystal structure from PDB file 4Q35.8 For LptD, the 
ß-barrel domain is shown in green/white and the ß-jelly-roll in orange. LptE is light 
blue. 
 
 
 Computational, mutagenesis and photo-crosslinking studies suggest that the 
lipid chains in LPS move along the hydrophobic cavity in the jelly-roll domain and 
exit into the outer leaflet of the OM through a transient lateral opening created 
between ß-strands-1 and -26 in the LptD ß-barrel domain.9-11 A similar architecture is 
expected for the LptD/E complex from P. aeruginosa, except that sequence 
comparisons show that an additional ≈90-residue domain of unknown structure and 
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function is inserted close to the N-terminus of the ß-jelly roll. This insert domain is a 
distinguishing feature of LptD in Pseudomonas spp. 
 Although the binding site for the peptidomimetic antibiotics in PA LptD has 
not yet been defined, the ß-hairpin fold of the macrocycle stabilized by a D-Pro-L-Pro 
template is thought to be important for antibiotic activity.1 An alanine-scan in the 
parent compound L27-11 (Figure-1A) showed that the side chains of Trp2 and Trp8, 
located on opposite faces of the ß-hairpin, are critical for activity.1 In this work, we 
explore the importance of individual peptide bonds for antimicrobial activity, by 
analyzing analogs of LB-01 containing N-methylated amino acid residues. Cross-
strand pairs of amino acids in ß-hairpins occupy alternately internal hydrogen-
bonding (HB) and non-hydrogen-bonding (NHB) positions.12 Residue pairs at NHB 
positions orient their amide NHs and carbonyl COs outward (Figure 1A), where they 
might engage hydrogen-bonding interactions with a receptor protein. If this occurs, 
peptide bond N-methylation may disrupt binding and lead to a loss of biological 
activity. We have used this approach to gain new insights into how the antibiotics 
interact with LptD, and to search for new analogs with potent antimicrobial activity. 
 
2. Results and Discussion 
Synthesis of N-methyl analogs 
The synthesis of LB-01 followed a previously described method, in which the linear 
sequence was assembled on 2-chlorotrityl chloride resin using Fmoc chemistry13 
starting with residue-6, the linear side-chain protected 14-mer peptide was cleaved 
from the resin with 0.7% TFA, macrocyclization was performed in solution, and 
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finally all side-chain protecting groups were removed using 95% TFA.1,14 The twelve 
N-methylated analogs of LB-01, each containing a single N-methyl residue in the 
hairpin loop, were prepared in the same way. Some of the necessary protected NMe 
amino acids were commercially available (Fmoc-NMe-Trp(Boc)-OH, Fmoc-NMe-
Leu-OH, Fmoc-NMe-Ala-OH) and could be incorporated using Fmoc chemistry. 
Other NMe residues were incorporated using the on-resin Mitsunobu methylation 
method developed by Kessler15 (Figure 2A). For the special case of the Thr1NMe 
analogue, where coupling of Fmoc-L-Pro-OH onto the resin bound highly hindered 
NMe-Thr(tBu) gave very low yields, an alternative strategy was used, wherein Fmoc-
Pro-NMe-Thr(tBu)-OH dipeptide (3) was first prepared, as shown in Figure 2B, and 
incorporated as a single unit during Fmoc peptide synthesis. All twelve mono N-
methylated analogs were obtained after HPLC purification in >95% purity by HPLC  
(Table 1, and supporting information), for NMR analyses and determination of 
antimicrobial activity. 
 
Figure 2. Synthesis of the NMe scan library on LB-01. A, Overview of the Fmoc-
chemistry used for peptide assembly, on-resin N-methylation chemistry and 
macrocyclization in solution. B, synthesis of the dipeptide fragment Fmoc-Pro-NMe-
Thr(OtBu)-OH. 
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Table 1. NMe scan of LB-01. After purification, each NMe analogue was analyzed 
by reverse-phase HPLC (tR retention time (min)) and MS (see supporting information 
for HPLC chromatograms). Calculated mass and experimental m/z values are shown 
(HPLC, C18 column, with a linear gradient of 10 to 60% MeCN/H2O+0.1% TFA). 
Peptidomimetic Exact mass (calc.) m/z (HR-ESI) tR (min) 
Thr1NMe 1706.02565 854.01996 [M+2H]2+ 
569.68292 [M+3H]3+ 
427.51393 [M+4H]4+ 
11.4 
Trp2NMe 1706.02565 854.02035 [M+2H]2+ 
569.68258 [M+3H]3+ 
427.51382 [M+4H]4+ 
10.8 
Leu3NMe 1706.02565 854.01884 [M+2H]2+ 
569.68228 [M+3H]3+ 
427.51364 [M+4H]4+ 
12.6 
Dab4NMe 1706.02565 854.01946 [M+2H]2+ 
569.68196 [M+3H]3+ 
427.51310 [M+4H]4+ 
10.9 
Orn5NMe 1706.02565 854.02013 [M+2H]2+ 
569.68328 [M+3H]3+ 
427.51416 [M+4H]4+ 
12.0 
DLys6NMe 1706.02565 854.01956 [M+2H]2+ 
569.68207 [M+3H]3+ 
427.51349 [M+4H]4+ 
10.6 
Arg7NMe 1706.02565 854.01911 [M+2H]2+ 
569.68236 [M+3H]3+ 
427.51394 [M+4H]4+ 
11.7 
Trp8NMe 1706.02565 854.01905 [M+2H]2+ 
569.68204 [M+3H]3+ 
427.51330 [M+4H]4+ 
11.4 
Orn9NMe 1706.02565 854.02048 [M+2H]2+ 
569.68328 [M+3H]3+ 
427.51441 [M+4H]4+ 
12.1 
Dab10NMe 1706.02565 854.01930 [M+2H]2+ 
569.68200 [M+3H]3+ 
11.3 
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427.51286 [M+4H]4+ 
Ala11NMe 1706.02565 854.01880 [M+2H]2+ 
569.68178 [M+3H]3+ 
427.51305 [M+4H]4+ 
11.0 
Lys12NMe 1706.02565 854.01921 [M+2H]2+ 
569.68255 [M+3H]3+ 
427.51400 [M+4H]4+ 
12.9 
 
 
Antimicrobial activity 
Minimum Inhibitory Concentrations (MICs) were determined by the microbroth 
dilution method in a microtitre plate format in Mueller-Hinton-I broth, using two P. 
aeruginosa strains. The results shown in Figure 3 reveal dramatic differences in 
antimicrobial activity against both strains within the NMe scan library. Notable is the 
complete loss in activity after N-methylation of residues on the lower part (proximal 
to the D-Pro-L-Pro template) on both sides of the predicted hairpin structure (residues 
2, 3, 11 or 12) and major losses in activity after N-methylation of Orn9 and Dab10. 
However, N-methylation of residues on the upper part, or tip of the hairpin (residues 4, 
5 , 6 and 8) largely retain or even show slightly improved activity compared to LB-01. 
Overall, methylations in the ß-strand residues 1-5 result in large variations in activity. 
However, the N-methylation of the backbone of most of the second ß-strand (residues 
9-11), strongly affects antimicrobial activity. The Thr1NMe analogue retains 
significant activity, which is remarkable given its location so close to the D-Pro-L-Pro 
template and the strong H-bonding interaction between the Thr1NH and the carbonyl 
of residue-12, seen in the NMR structure of LB-01.1 
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Figure 3. Antimicrobial activity (MIC, µg/mL) of the NMe scan library on LB-01. 
 
 A more detailed analysis of these structure-activity relationships now rests 
upon an understanding of how each N-methylation affects the folded ß-hairpin 
conformation of the macrocycle, which in LB-01 is characterized by two regular ß-
strands (residues 1-5 and 8-12) and stable type-II' ß-turns in the template and at the 
hairpin tip (residues 6 and 7).1 
NMR Studies and SAR 
The cyclic peptide LB-01 is a single rotamer (>98%) in aqueous solution with all 
peptide bonds trans.1 The backbone adopts a stable folded ß-hairpin conformation 
according to several NMR criteria, including 3JHNHα values ≥8.0 Hz typical of residues 
in the ß-region of φ/ψ-space;16 mostly positive NMR chemical shift deviations (CSDs) 
(Δδ = δobserved - δrandom) for Hα indicative of regular ß-structure;17,18 and a network of 
long range cross-strand NOEs in 2D NOESY plots characteristic of a folded ß-hairpin 
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structure. Both the tip region (DLys6-Arg7) and the template (DPro13-LPro14) in LB-
01 adopt stable type-II' ß-turn structures.1 
cis-trans conformational isomers (rotamers) 
Whereas several of the NMe analogues exist predominantly (≥95%) with all-trans 
peptide bonds, both at the site of N-methylation and at the Lys12-D-Pro13 peptide 
bond, the situation becomes more complex for some others (Table 2). The Trp8NMe 
analogue exists as 1:1 trans-cis at Arg7-TrpNMe8 and the Leu3NMe analogue as 3:1 
trans-cis at Trp2-Leu3NMe. Both Orn9NMe and Dab10NMe analogues show 
resonances for cis-trans rotamers at both the site of methylation and at D-Pro13, 
indicating an even more complex conformational behavior in these macrocycles. 
Trp2NMe and Ala11NMe 
 
 
Table 2. Occurrence of cis-trans peptide bond rotamers in peptides detected by 1H-
NMR. 
peptide cis rotamers 
(%) 
amide bonds  
LB-01 < 5%  
Thr1NMe 7% LPro-Thr1NMe 
Trp2NMe 7%  Thr1-Trp2NMe 
Leu3NMe 25% Trp2-Leu3NMe 
Dab4NMe 5%  Leu3-Dab4NMe 
Orn5NMe < 5%   
DLys6NMe < 5%   
Arg7NMe < 5%   
Trp8NMe 50 % Arg7-Trp8NMe 
Orn9NMe 25%,  
12% 
Trp8-Orn9NMe,  
Lys12-DPro13 
Dab10NMe 25%,  
8%  
Orn9-Dab10NMe 
Lys12-DPro13 
Ala11NMe 8% Dab10-Ala11NMe 
Lys12NMe 10% Ala11-Lys12NMe 
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 Two of the four analogues that completely lose activity (Trp2NMe and 
Ala11NMe; Figure 3) are at a cross-strand NHB position with their NH(or Me) 
groups oriented outwards. Yet both these NMe analogues retain a folded ß-hairpin 
structure in solution. This is apparent from the numerous cross-strand NOEs seen in 
NOESY plots of each analogue, the mostly positive CSDs characteristic of Hα 
protons and 3JHNα values ≥8.0 Hz, both typical of residues in the ß-region of φ/ψ-space 
(Figure 4A-C). Structure calculations using NOE-derived distance restraints yielded 
average solution structures for the Ala11NMe and Trp2NMe analogues, with well-
defined ß-hairpin backbones (shown in Figure 4D). Hence the loss in activity in both 
is not caused by a loss of the folded ß-hairpin backbone structure. Rather, the results 
provide evidence that both amide NH groups of Trp2 and Ala11 make critical 
contacts to the receptor LptD, which are disrupted by N-methylation. An alternative 
explanation, that N-methylation might prevent permeation to the binding site on LptD 
seems less likely, since LptD is exposed to the medium in the OM. 
Leu3NMe and Lys12NMe 
The Leu3NMe and Lys12NMe analogues also have no activity, which can be 
explained by the NH groups in these two amino acids being involved in internal 
hydrogen bonds in the parent peptide (Figure 3). Signal overlap in their 1H-NMR 
spectra precluded a detailed analysis of the cis-rotamers (Table 2), but the minor 
occurrence of cis rotamers cannot alone account for the complete loss in antimicrobial 
activity seen for both. More telling, 1H NOESY data reveal for the trans rotamers 
NOEs that cannot be reconciled with regular ß-hairpin structures (Figure 4A). A 
network of cross-strand NOEs characteristic of folded ß-hairpin conformations are not 
seen. In addition, 3JHNα values <8.0 Hz, and CSDs uncharacteristic of ß-structure 
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(Figure 4B/C), all suggest that quite different backbone conformations are present. 
We speculate that the loss of ß-hairpin structure is likely due to loss of cross-strand H-
bonding interactions, likely combined with deleterious cross-strand steric interactions 
when the new NMe groups are present. A similar complete loss of antimicrobial 
activity correlating with loss of ß-hairpin structure was observed earlier in another 
analogue of LB-01 in which the D-Pro13-L-Pro14-template was changed to L-Pro13-D-
Pro14.1 
Orn9NMe and Dab10NMe 
The Orn9NMe and Dab10NMe analogues retain weak antimicrobial activity. Orn9 is 
at a NHB position in the LB-01 ß-hairpin, whereas Dab10 is at an internal HB 
position. Only a few long range NOEs are seen in NOESY plots for each analogue, 
and some observed NOEs are not compatible with stable regular ß-hairpin structures 
(Figure 4A). The pattern of CSDs observed for both also indicate non-ß backbone 
conformers. We must conclude, therefore, that weak activity in these two analogues 
(compared to LB-01) could be due to steric hindrance from the new NMe group upon 
receptor binding and/or changed (i.e. non-ß-hairpin) global backbone macrocycle 
conformations. 
Other NMe analogues 
The remaining analogues (Thr1NMe, Dab4NMe, Orn5NMe, DLys6NMe, Arg7NMe, 
Trp8NMe) all retain significant antimicrobial activity, which in the case of Dab4NMe 
and Orn5NMe are comparable or even slightly improved compared to LB-01 (Figure-
3).  
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Figure 4. NMR studies. A, long range NOEs observed in NOESY plots for the 
analogues shown. B, coupling constants (3JHNHα, Hz) for selected analogues discussed 
in the text. C, chemical shift deviations (CSDs) (Δδ = δobserved - δrandom) of Hα 
resonances of residues 1-12 in selected analogues. Positive values are expected for 
residues in ideal ß-structure. D, Average NMR backbone structures (side chains 
omitted for clarity) for selected analogues; 20 selected structures and one typical 
structure for Thr1NMe are shown. For each, the D-Pro-L-Pro template and residue 
number is indicated (compare A); N atoms in blue; O-atoms in red. 
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The Thr1NMe analogue is of special interest, since in LB-01 the D-Pro-L-Pro 
template is expected to direct the Thr1NH into a hydrogen-bonding interaction with 
the Lys12 carbonyl group. However, in the Thr1NMe analogue, the NMe group must 
be oriented away from the Lys12 CO to avoid a steric clash. Nevertheless, the 
Thr1NMe analogue shows a large number of cross-strand NOEs. Calculated 
structures for this analogue (Figure 4D) suggest that a distortion from regular ß-
structure must occur in the critical segment of the backbone close to the template, 
which most likely also explains the reduced antimicrobial activity of this analogue. 
 The remaining analogues, with NMe groups in the tip region retain excellent 
antimicrobial activity and hence an ability to interact with the target LptD. Only the 
Arg7NMe analogue suffers a ≈50 fold reduction in the MIC, possibly due to steric 
clashes between LptD and the hairpin tip. The outward-facing backbone NH groups 
of Dab4 and DLys6 largely retain antimicrobial activity upon N-methylation and so 
are unlikely to directly mediate contacts to LptD. Clearly, the inward facing Orn5 NH 
can also readily accommodate N-methylation upon interaction with LptD. 
 
3. Conclusions 
Almost all OM proteins in Gram-negative bacteria are rich in ß-structure, as seen in 
the ß-barrel and ß-jelly-roll domains of LptD from S. flexneri (Figure 1C). Ligands 
containing folded ß-hairpin structures might be well suited to interact with such ß-rich 
proteins through antiparallel strand-strand interactions, as illustrated in Figure 5. One 
intriguing possibility is that binding of the antibiotics occurs to transient LptD 
structures that arise during LPS transport to the bacterial cell surface. LptD along with 
several other OM proteins in Gram-negative bacteria are believed to transport 
substrates into the membrane through lateral gates formed by transient opening of the 
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Figure 5. The folded ß-hairpin structure of LB-01 and possible interactions with 
neighboring ß-strands in the target protein LptD (in bold). Dotted lines indicate H-
bonding interactions between LB-01 and LptD suggested by the NMe-scan. 
 
 
first and last ß-strands in the ß-barrel.8,9,11,19,20 Such complex dynamic processes might 
create a binding site for the antibiotic between antiparallel ß-strands, allowing H-
bonding interactions to both sides of the antibiotic ß-hairpin (Figure 5). Access to 
such a binding site might also be possible from the cell exterior, following initial 
electrostatic attraction of the cationic antibiotic to anionic LPS molecules in the outer 
leaflet. The results described here provide some support for such a binding mode, by 
showing that outward-facing peptide NH groups on both sides of the ß-hairpin 
structure of LB-01 are sensitive to N-methylation, in particular, N-methylation of 
Trp2, Ala11 and Orn9 leads to major losses of antimicrobial activity. Moreover, 
whenever N-methylation at other positions leads to disruption of the folded ß-hairpin 
structure, large losses of antimicrobial activity are also observed, reinforcing the 
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conclusion from earlier studies1 that the regular ß-hairpin structure is crucial for 
optimal antimicrobial activity and binding to LptD. 
 
4. Experimental Section 
Peptide synthesis. Peptides were assembled on 2-chlorotrityl chloride resin with Fmoc 
chemistry on a 0.25 mmol scale with an Applied Biosystems ABI433A synthesizer 
and a Perkin-Elmer785A UV/VIS detector for reaction monitoring. Couplings were 
performed with HBTU/HOBt (4 eq.) in NMP and DIPEA (8 eq.), and Fmoc 
deprotection was with 20% piperidine in NMP. Macrocyclization in solution was 
performed as described earlier.14 Analytical HPLC was performed on an Amersham 
Aekta Purifier 100 system with an Agilent C18 4.6 × 250 mm column with 5 μm 
particle size (1 mL/min), and a C18 21.2 × 250 mm column with 7 μm particle size on 
preparative scale (17 mL/min). Linear gradients ranged from 10 to 60% MeCN/H2O 
with 0.1% TFA. High-resolution electrospray ionization spectra (HR-ESI) were 
recorded using a Bruker MaXis spectrometer (accuracy ±1ppm). 1H-, 13C- and 2D-
NMR spectra were recorded on Bruker AV-400 or AV-600 instruments at room 
temperature. Chemical shifts (δ) are reported in ppm and are referenced to TMS or 
TSP (0 ppm) as internal standard. 
 
(2S,3R)-Methyl-2-(((benzyloxy)carbonyl)(methyl)amino)-3-(tert-
butoxy)butanoate (1) 
Z-Thr(tBu)-OH dicylohexylamine salt (1.00 g, 2.04 mmol) was converted to the free 
acid by treatment with aq. citric acid 5% and extraction into Et2O (3 x 20 ml). Ag2O 
(1.89 g, 8.16 mmol) was added to a solution of Z-Thr(tBu)-OH free acid and MeI 
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(1.91 ml, 30.6 mmol) in DMF (7 ml) and stirred overnight at room temperature. 
CH2Cl2  (15 mL) was then added and the solution was filtered through celite. The 
filter cake was washed with CH2Cl2 (3 x 20 mL), and the combined organic phases 
were washed with 15% aq. Na2S2O3 (2 x 30 mL), water (3 x 30mL) and brine (30 mL). 
After drying (MgSO4) the combined organic phases were concentrated in vacuo and 
the oily residue was purified by flash column chromatography (4:1 
cyclohexane/EtOAc) yielding 647 mg of colourless oil (1) (94% yield). TLC (silica): 
Rf 0.50 (hexane/EtOAc 4:1). [α]D24: +3.5° (c 0.65, MeOH). 1H-NMR (CDCl3): two 
rotamers with an approx. 2:1 ratio. Major: δ =7.39 – 7.27 (m, 5H), 5.21 – 5.04 (m, 
2H), 4.82 (d, J=4.3 Hz, 1H), 4.41-4.35 (m, 1H), 3.70 (s, 3H) 3.14 (s, 3H), 1.86 (d, 
J=6.2 Hz, 3H), 1.28 (s, 9H). Minor: δ =7.39 – 7.27 (m, 5H), 5.21 – 5.04 (m, 2H), 4.59 
(d, J= 5.1 Hz, 1H), 4.30-4.24 (m, 1H), 3.65 (s, 3H), 3.11 (s, 3H), 1.58 (d, J=6.2 Hz, 
3H), 1.12 (s, 9H). 13C-NMR (CDCl3): Major: δ = 170.7, 157.6, 136.8, 128.5, 128.0, 
127.9, 127.6, 74.0, 68.4, 67.4, 64.1, 51.7, 33.6, 28.7, 20.5. Minor: δ = 170.5, 156.4, 
136.6, 128.5, 128.0, 127.9, 127.6, 74.1, 67.9, 67.4, 64.4, 51.7, 34.1, 28.7, 20.7. HR-
ESI: calc. for C22H25NNaO4 [M+Na]+ 390.1676, found 390.1672. 
 
(R)-(9H-Fluoren-9-yl)methyl 2-(((2S,3R)-3-(tert-butoxy)-1-methoxy-1-oxobutan-
2-yl) (methyl)carbamoyl)pyrrolidine-1-carboxylate (2) 
To the foregoing dipeptide (1) (294 mg, 0.87 mmol) in THF (9 mL) was added Pd/C 
(10%, 93 mg, 0.09 mmol), and stirred for 30 min under H2. The solution was then 
filtered through celite, washed with THF and dried under vacuo. COMU (746 mg, 
1.74 mmol) was added to a mixture of Fmoc-Pro-OH (588 mg, 1.74 mmol), the 
dipeptide and DIPEA (445 µl, 2.61 mmol) in DMF (9 ml) at 0°C. The reaction 
mixture was warmed to RT and stirred for 2 h. The mixture was then diluted with 
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EtOAc (25 ml) and washed with aq. citric 5% (2 x 15 ml), 1M NaHCO3 (2 x 15 ml) 
and saturated NaCl (2 x 15 ml). The organic layer was then dried over MgSO4 and the 
solvent removed in vacuo. The residue was purified by flash column chromatography 
(2:1 (v/v) cyclohexane/EtOAc then 1:1 (v/v) cyclohexane/EtOAc), to give 2 yield: 
327 mg reddish foam that solidified overnight (72% yield). TLC: Rf 0.47 
(cyclohexane/EtOAc, 1:1). M.p. 64 - 68 °C. [α]D24: -42.3 ° (c 0.22, MeOH). 1H-NMR 
(CDCl3): Two rotamers with approx. 2:1 ratio, each with a low abundance rotamer 
from the N-methyl-amide (not assigned). 1H-NMR (CDCl3): Major: δ = 7.78 - 7.73 
(m, 2H), 7.67 - 7.55 (m, 2H), 7.42 - 7.35 (m, 2H), 7.34 - 7.27 (m, 2H), 5.35 (s, J = 3.5 
Hz, 1H), 4.86 (dd, J = 8.4 Hz, 1H), 4.47 - 4.41 (m, 1H), 4.41 - 4.37 (m, 1H), 4.33 - 
4.26 (m, 1H), 4.30 - 4.24 (m, 1H), 3.70 (s, 3H), 3.80 - 3.72 (m, 1H), 3.62 - 3.56 (m, 
1H), 3.34 (s, 3H), 2.30 - 2.21 (m, 1H), 2.05 - 1.96 (m, 1H), 2.20 - 2.09 (m, 1H), 2.03 - 
1.92 (m, 1H), 1.20 (d, J = 6.3 Hz, 3H), 1.14 (s, 9H). Minor: δ = 7.78 - 7.73 (m, 2H), 
7.67 - 7.55 (m, 2H), 7.42 - 7.35 (m, 2H), 7.34 - 7.27 (m, 2H), 5.29 (s, J = 3.5 Hz, 1H), 
4.65 (dd, J = 8.4 Hz, 1H), 4,71 - 4.65 (m, 1H), 4.41 - 4.35 (m, 1H), 4.23 - 4.16 (m, 
1H), 4.21 - 4.16 (m, 1H), 3.68 (s, 3H), 3.69 - 3.63 (m, 1H), 3.56 - 3.47 (m, 1H), 3.15 
(s, 3H), 2.30 - 2.21 (m, 1H), 2.02 - 1.95 (m, 1H), 2.04 - 1.96 (m, 1H), 2.91 - 1.82 (m, 
1H),1.09 (s, 9H), 0.93 (d, J = 6.3 Hz, 3H). 13C-NMR (100 MHz): Major: δ = 174.1, 
170.7, 154.8, 144.3, 144.0, 141.3, 127.6, 127.0, 125.4, 125.2, 119.9, 74.0, 68.8, 67.4, 
61.5, 57.0, 51.7, 47.2, 47.6, 34.4, 29.2, 28.7, 24.3, 20.3. Minor: δ = 173.9, 170.5, 
154.3, 144.4, 143.9, 141.3, 127.6, 127.1, 127.0, 125.3, 125.1, 119.9, 119.8, 74.1, 68.5, 
66.9, 61.4, 56.8, 51.7, 47.4, 46.9, 34.0, 30.2, 28.7, 23.0, 20.2. HR-ESI: calculated for 
C22H25NNaO4 [M+Na]+ 390.1676, found 390.1672. 
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(2S,3R)-2-((R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-methylpyrrolidine-2-
carboxamido)-3-(tert-butoxy)butanoic acid (3) 
To the foregoing methyl ester (2) (265 mg, 0.51 mmol) in EtOAc (5 mL) was added 
LiI (679 mg, 5.07 mmol). The mixture was refluxed for 16 h. After cooling, water 
was added and the solution acidified with aq. citric acid 5% to pH 3, and extracted 
with EtOAc (3 x 20 ml). The combined organic phases were dried over MgSO4 and 
concentrated in vacuo. The product (3) was purified by flash column chromatography 
(19:1 to 4:1 v/v CH2Cl2/MeOH) yielding 203 mg of a white solid (79% yield). M.p. 
96 - 99 °C. TLC: Rf : 0.51 (9:1 CH2Cl2/MeOH). [α]D24: -34.8° (c 0.23, MeOH) 
Two rotamers with an approximate ratio of 1:1 (Fmoc-amide rotation) are apparent by 
NMR, each with a low abundance rotamer deriving from the N-methyl-amide (not 
assigned). 1H-NMR (DMSO-d6): Rotamer 1: δ = 12.80 - 12.62 (br, 1H), 7.92 - 7.85 
(m, 2H), 7.70 - 7.53 (m, 2H), 7.45- 7.39 (m, 2H), 7.37 - 7.26 (m, 2H), 4.79 (d, J=3.7 
Hz, 1H), 4.75 - 4.68 (m, 1H), 4.38 - 4.34 (m, 1H), 4.27 - 4.21 (m, 2H), 4.17 - 4.11 (m, 
1H), 3.49-3.39 (m, 2H), 3.16 (s, 3H), 2.32 - 2.18 (m, 1H), 1.83 - 1.76 (m, 2H), 1.79 - 
1.73 (m, 1H), 1.12 (s, 9H), 1.04 (d, J = 6.3 Hz, 3H). Rotamer 2: δ = 12.80 - 12.62 (br, 
1H), 7.92 - 7.85 (m, 2H), 7.70 - 7.53 (m, 2H), 7.45 - 7.39 (m, 2H), 7.37 - 7.26 (m, 
2H), 5.01 (d, J = 3.7Hz, 1H), 4.75 - 4.68 (m, 1H), 4.44 - 4.38 (m, 1H), 4.34 - 4.29 (m, 
1H), 4.28 - 4.23 (m, 1H), 4.14 - 4.07 (m, 1H), 3.49 - 3.39 (m, 2H), 3.08 (s, 3H), 2.32 - 
2.18 (m, 1H), 1.91 - 1.83 (m, 2H), 1.75 - 1.69 (m, 1H), 1.06 (s, 9H), 0.88 (d, J = 6.3 
Hz, 3H). 13C-NMR (DMSO-d6): Rotamer 1: δ =172.9, 171.5, 153.6, 143.9, 143.8, 
140.7, 127.6, 127.1, 125.2, 120.1, 73.2, 67.9, 66.4, 61.2, 56.6, 47.1, 46.9, 33.7, 29.6, 
28.5, 23.7, 20.5. Rotamer 2: δ = 172.8, 171.3, 153.6, 143.8, 143.4, 140.7, 127.6, 
127.1, 125.1, 120.0, 73.2, 67.8, 66.2, 60.9, 56.4, 46.6, 46.4, 33.6, 28.6, 28.5, 23.7, 
20.3. HR-ESI: calculated for C29H36N2NaO6 [M+Na]+ 531.24715, found 531.24656. 
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NMR structure calculations 
1H NMR spectra were measured in H2O/D2O (9:1) or pure D2O at pH 3 on a Bruker 
AV-600 spectrometer at 300 K. Water suppression was performed by presaturation. 
Spectral assignments were made using standard methods from 2D DQF-COSY, 
TOCSY and NOESY spectra. 3JHNHα  coupling constants were determined from 1D 
spectra or in the case of signal overlap from 2D NOESY spectra by inverse Fourier 
transformation of in-phase multiplets. Spectra were typically collected with 1024 x 
256 complex data points zero-filled prior to Fourier transformation to 2048 x 1024, 
and transformed with a cosine-bell weighting function. Distance restraints were 
obtained from NOESY spectra with a mixing time of 250 ms. The structure 
calculations were performed by restrained molecular dynamics in torsion angle space 
by applying the simulated annealing protocol implemented in the program CYANA.21 
Starting from 100 randomized conformations a bundle of 20 conformations is selected, 
which incur the lowest CYANA target energy function (see Supporting information). 
MOE (Chemical Computing Group, Quebec, Canada) was used for structure analysis 
and visualization of the molecular models. 
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